ANTI-INFLAMMATION COMPOUNDS
The present invention relates to small molecule compounds and use thereof for treating inflammatory diseases, especially asthma, chronic obstructive pulmonary disease (COPD), inflammation after infection, arthritis, atherosclerosis, schmerz, and dermatitis. In one aspect, the present invention relates to a compound, which is presented by chemical formula I and is used for treating inflammatory diseases, and pharmaceutically acceptable salts thereof. The purpose of the present invention is identifying a compound having an effect of inhibiting arachidonate 5-lipoxygenase..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Europäisches Patentamt - (2018) vom: 27. Sept. Zur Gesamtaufnahme - year:2018 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Beteiligte Personen: |
NO ZAE SUNG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2018-09-27, Last updated: 2021-03-11 |
|---|
| Patentnummer: |
KR20140093610 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA006891268 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006891268 | ||
| 003 | DE-627 | ||
| 005 | 20230504091011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2018 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)EPA006891268 | ||
| 035 | |a (EPA)KR20140093610 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 100 | 0 | |a NO ZAE SUNG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ANTI-INFLAMMATION COMPOUNDS |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2018-09-27, Last updated: 2021-03-11 | ||
| 520 | |a The present invention relates to small molecule compounds and use thereof for treating inflammatory diseases, especially asthma, chronic obstructive pulmonary disease (COPD), inflammation after infection, arthritis, atherosclerosis, schmerz, and dermatitis. In one aspect, the present invention relates to a compound, which is presented by chemical formula I and is used for treating inflammatory diseases, and pharmaceutically acceptable salts thereof. The purpose of the present invention is identifying a compound having an effect of inhibiting arachidonate 5-lipoxygenase. | ||
| 650 | 4 | |a C07D | |
| 650 | 4 | |a A61K | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61P | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a KIM JAE SEONG |e verfasserin |4 aut | |
| 700 | 0 | |a HAN SEONG JUN |e verfasserin |4 aut | |
| 700 | 0 | |a KIM JEONG HWAN |e verfasserin |4 aut | |
| 700 | 0 | |a PARK YOUNG SAM |e verfasserin |4 aut | |
| 700 | 0 | |a LEE SANG CHUL |e verfasserin |4 aut | |
| 700 | 0 | |a NAM KI YEAN |e verfasserin |4 aut | |
| 700 | 0 | |a KIM JEONG JUN |e verfasserin |4 aut | |
| 700 | 0 | |a LEE JIN HWA |e verfasserin |4 aut | |
| 700 | 0 | |a KANG SUN HEE |e verfasserin |4 aut | |
| 700 | 0 | |a SEO MIN JUNG |e verfasserin |4 aut | |
| 700 | 0 | |a LEE SE YEON |e verfasserin |4 aut | |
| 700 | 0 | |a CHOI GA HEE |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2018) vom: 27. Sept. |
| 773 | 1 | 8 | |g year:2018 |g day:27 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/searchResults?DB=EPODOC&locale=en_EP&query=KR20140093610A |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2018 |b 27 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2018 |b 27 |c 09 | ||